LOCHOLEST LIGHT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Locholest Light, and when can generic versions of Locholest Light launch?
Locholest Light is a drug marketed by Chartwell Rx and is included in one NDA.
The generic ingredient in LOCHOLEST LIGHT is cholestyramine. There are eight drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Locholest Light
A generic version of LOCHOLEST LIGHT was approved as cholestyramine by EPIC PHARMA LLC on August 15th, 1996.
Summary for LOCHOLEST LIGHT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | LOCHOLEST LIGHT at DailyMed |
Pharmacology for LOCHOLEST LIGHT
| Drug Class | Bile Acid Sequestrant |
| Mechanism of Action | Bile-acid Binding Activity |
US Patents and Regulatory Information for LOCHOLEST LIGHT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Rx | LOCHOLEST LIGHT | cholestyramine | POWDER;ORAL | 074562-001 | Aug 15, 1996 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Chartwell Rx | LOCHOLEST LIGHT | cholestyramine | POWDER;ORAL | 074562-002 | Aug 15, 1996 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
